Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna
Selma Tobudic(Medical University of Vienna), Christina Forstner(Jena University Hospital), Heinz Burgmann(Medical University of Vienna), Heimo Lagler(Medical University of Vienna), Michael Ramharter(Medical University of Vienna), Christoph Steininger(Medical University of Vienna), Matthias G. Vossen(Medical University of Vienna), Stefan Winkler(Medical University of Vienna), Florian Thalhammer(Medical University of Vienna)
Cited by 184Open Access
Abstract
The clinical outcomes and safety of dalbavancin as primary and sequential treatment of gram-positive bacteremia with infective endocarditis were evaluated retrospectively. The clinical success rate was high (92.6%), but in 24 of 27 patients dalbavancin was used only after clearance of bacteria from the bloodstream.
Related Papers
No related papers found
Powered by citation graph analysis